Organisation paid for research Program year 2020 Source: CMS Open Payments

Alfieri Cardiology

Neither a doctor nor a teaching hospital

Research payments

$15,491

4 payments

Through program year 2020, Alfieri Cardiology is reported as receiving $15,491 in research payments, across 4 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$9,956	2
2019	Research	$5,535	2

Breakdown

Who paid Research payments · program years 2019–2020

AstraZeneca Pharmaceuticals LP $7,200 1 payment
Lantheus Medical Imaging, Inc. $5,290 1 payment
Novartis Pharmaceuticals Corporation $2,756 1 payment
Amgen Inc. $245 1 payment

Studies the money was for Research payments · program years 2019–2020

An International, Double-blind, Randomised, Placebo-Controlled Phase IIIb Study to Evaluate the Effect of Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF) $7,200 1 payment
DEF-315 Better Accuracy in EF Assessment With DEFINITY BENEFIT2 $5,290 1 payment
Observational Registry of Treatment Patterns in US Heart Failure Patients With Reduced Ejection Fraction $2,756 1 payment
P4-AA Heart Failure Registry $245 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.